Jaime Acquaviva

1.3k total citations
21 papers, 1.1k citations indexed

About

Jaime Acquaviva is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jaime Acquaviva has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jaime Acquaviva's work include Heat shock proteins research (13 papers), ATP Synthase and ATPases Research (6 papers) and Cancer therapeutics and mechanisms (3 papers). Jaime Acquaviva is often cited by papers focused on Heat shock proteins research (13 papers), ATP Synthase and ATPases Research (6 papers) and Cancer therapeutics and mechanisms (3 papers). Jaime Acquaviva collaborates with scholars based in United States and United Kingdom. Jaime Acquaviva's co-authors include Al Charest, David A. Proia, Jim Sang, Donald L. Smith, Chaohua Zhang, Suqin He, Manuel Sequeira, Ricky Ngok‐Shun Wong, Richard C. Bates and Julie C. Friedland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Jaime Acquaviva

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaime Acquaviva United States 14 750 327 320 184 123 21 1.1k
Babita Saigal United States 15 723 1.0× 460 1.4× 288 0.9× 175 1.0× 98 0.8× 26 1.2k
Katharine Ellwood‐Yen United States 8 787 1.0× 336 1.0× 531 1.7× 287 1.6× 113 0.9× 10 1.3k
Yoko Ueno Japan 13 901 1.2× 377 1.2× 217 0.7× 123 0.7× 162 1.3× 19 1.4k
J. Rafael Sierra United States 11 582 0.8× 364 1.1× 249 0.8× 133 0.7× 71 0.6× 18 1.1k
Susan Korenchuk United States 13 896 1.2× 348 1.1× 462 1.4× 204 1.1× 48 0.4× 18 1.4k
Jay Gibbons United States 11 1.1k 1.4× 358 1.1× 345 1.1× 243 1.3× 156 1.3× 14 1.5k
Wells S. Brown United States 15 552 0.7× 266 0.8× 139 0.4× 206 1.1× 98 0.8× 24 895
Michael Zinda United States 22 935 1.2× 469 1.4× 192 0.6× 188 1.0× 135 1.1× 37 1.4k
Alexandra Florin Germany 19 691 0.9× 388 1.2× 186 0.6× 302 1.6× 73 0.6× 27 1.1k
Sean Caenepeel United States 16 817 1.1× 433 1.3× 138 0.4× 145 0.8× 74 0.6× 22 1.3k

Countries citing papers authored by Jaime Acquaviva

Since Specialization
Citations

This map shows the geographic impact of Jaime Acquaviva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Acquaviva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Acquaviva more than expected).

Fields of papers citing papers by Jaime Acquaviva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Acquaviva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Acquaviva. The network helps show where Jaime Acquaviva may publish in the future.

Co-authorship network of co-authors of Jaime Acquaviva

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Acquaviva. A scholar is included among the top collaborators of Jaime Acquaviva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Acquaviva. Jaime Acquaviva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
London, Cheryl A., Jaime Acquaviva, Donald L. Smith, et al.. (2018). Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors. Clinical Cancer Research. 24(24). 6396–6407. 8 indexed citations
2.
Proia, David A., Donald L. Smith, Junyi Zhang, et al.. (2015). HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors. Molecular Cancer Therapeutics. 14(11). 2422–2432. 29 indexed citations
3.
Acquaviva, Jaime, Donald L. Smith, John-Paul Jimenez, et al.. (2014). Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib. Molecular Cancer Therapeutics. 13(2). 353–363. 79 indexed citations
4.
Acquaviva, Jaime, Suqin He, Chaohua Zhang, et al.. (2014). FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism. Molecular Cancer Research. 12(7). 1042–1054. 57 indexed citations
5.
Acquaviva, Jaime, Suqin He, Jim Sang, et al.. (2014). mTOR Inhibition Potentiates HSP90 Inhibitor Activity via Cessation of HSP Synthesis. Molecular Cancer Research. 12(5). 703–713. 40 indexed citations
6.
Smith, Donald L., Jaime Acquaviva, Manuel Sequeira, et al.. (2014). The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer. Targeted Oncology. 10(2). 235–245. 31 indexed citations
7.
He, Song, John-Paul Jimenez, Manuel Sequeira, et al.. (2014). 585 The investigational HSP90 inhibitor ganetespib displays robust single agent activity in gastric cancer models both as monotherapy and in combination with standard of care therapeutics. European Journal of Cancer. 50. 188–189. 1 indexed citations
8.
Friedland, Julie C., Donald L. Smith, Jim Sang, et al.. (2013). Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes. Investigational New Drugs. 32(1). 14–24. 46 indexed citations
9.
Sang, Jim, Jaime Acquaviva, Julie C. Friedland, et al.. (2013). Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer. Cancer Discovery. 3(4). 430–443. 174 indexed citations
10.
Proia, David A., Chaohua Zhang, Manuel Sequeira, et al.. (2013). Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer. Clinical Cancer Research. 20(2). 413–424. 53 indexed citations
11.
He, Suqin, Jaime Acquaviva, Julie C. Friedland, et al.. (2013). Abstract 1038: Inhibition of mTOR enhances the activity of HSP90 inhibitors in part through cessation of heat shock protein synthesis.. Cancer Research. 73(8_Supplement). 1038–1038. 1 indexed citations
12.
Acquaviva, Jaime, Donald L. Smith, Jim Sang, et al.. (2012). Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib. Molecular Cancer Therapeutics. 11(12). 2633–2643. 83 indexed citations
13.
He, Suqin, Chaohua Zhang, Ayesha A. Shafi, et al.. (2012). Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression. International Journal of Oncology. 42(1). 35–43. 50 indexed citations
14.
Acquaviva, Jaime, et al.. (2012). Abstract B1: Targeting KRAS mutant NSCLC with the Hsp90 inhibitor ganetespib. Clinical Cancer Research. 18(3_Supplement). B1–B1. 1 indexed citations
15.
Proia, David A., Jaime Acquaviva, Qin Jiang, et al.. (2012). Preclinical activity of the Hsp90 inhibitor, ganetespib, in ALK- and ROS1-driven cancers.. Journal of Clinical Oncology. 30(15_suppl). 3090–3090. 3 indexed citations
16.
Acquaviva, Jaime, Julie Lessard, Huijun Zhu, et al.. (2011). Chronic Activation of Wild-Type Epidermal Growth Factor Receptor and Loss of Cdkn2a Cause Mouse Glioblastoma Formation. Cancer Research. 71(23). 7198–7206. 1 indexed citations
17.
Jun, Hyun Jung, Jaime Acquaviva, Julie Lessard, et al.. (2011). Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme. Oncogene. 31(25). 3039–3050. 8 indexed citations
18.
Schatz, Jonathan H., et al.. (2010). Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood. 116(15). 2759–2767. 26 indexed citations
19.
Zhu, Haihao, Jaime Acquaviva, Abraham Boskovitz, et al.. (2009). Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proceedings of the National Academy of Sciences. 106(8). 2712–2716. 172 indexed citations
20.
Acquaviva, Jaime, Ricky Ngok‐Shun Wong, & Al Charest. (2008). The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1795(1). 37–52. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Babita Saigal Breakdown of academic impact, for papers by Katharine Ellwood‐Yen Breakdown of academic impact, for papers by Yoko Ueno Breakdown of academic impact, for papers by J. Rafael Sierra Breakdown of academic impact, for papers by Susan Korenchuk Breakdown of academic impact, for papers by Jay Gibbons Breakdown of academic impact, for papers by Wells S. Brown Breakdown of academic impact, for papers by Michael Zinda Breakdown of academic impact, for papers by Alexandra Florin Breakdown of academic impact, for papers by Sean Caenepeel
Rankless by CCL
2026